Startup aims for clinical trials of microglia-targeting FTD treatment that ‘reprograms’ the brain’s immune system into a protective state. Neuro-focused … Continue reading "Modulo Bio lands $4.8m ADDF investment to...
New RNAi therapeutic offers a novel mechanism to address both cardiomyopathy and polyneuropathy manifestations of the disease. The US Food … Continue reading "Alnylam’s AMVUTTRA wins FDA nod for ATTR-related...
Epigenetic reprogramming startup identifies multiple sets of transcription factors with potential in liver disease and immune dysfunction. As Life Biosciences … Continue reading "NewLimit restores ‘youthful function’ to liver and...
TruDiagnostic Founder Ryan Smith on personalized testing, disease risk prediction and how lifestyle choices can rewrite your health future. Longevity … Continue reading "‘Epigenetic testing puts control back into our...
Researchers have improved multiple health metrics in prematurely aged mice by re-establishing the production of neuropeptide Y in the hypothalamus [1]. An essential protein Age-related decline in the function of...
A new study published in Nature Metabolism suggests that even a short period of eating loads of sweet and fatty snacks can cause brain changes reminiscent of those seen in...
